Amneal Pharmaceuticals Inc.
AMRX | NASDAQ
$19.20
-$0.96 (-4.76%)
Sep 22, 2026, 1:21 PM ET · Market open
Fiscal Quarter Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Income | 69.61M | 78M | 49.57M | 18.13M | 35.61M | 24.62M | -20.74M | 11.76M | 5.99M | -81.68M | -93.34M | 25.03M | 29.68M | -10.09M | -4.33M | -2.69M | -240.08M | -2.16M | -6.38M | -4.24M | 14.53M | 6.71M |
Depreciation & Amortization | 47.8M | n/a | 49.23M | 54.07M | 60.11M | 60.16M | 66.13M | 58.96M | 63.02M | 55.53M | 56.93M | 57.21M | 57.11M | 58.15M | 63.16M | 63.71M | 59.7M | 57.82M | 63.51M | 60.19M | 56.49M | 55.55M |
Stock-Based Compensation | 10.39M | n/a | 8.2M | 8.22M | 8.27M | 7.26M | 7.21M | 7.11M | 6.72M | 6.72M | 5.97M | 6.69M | 6.56M | 7.6M | 7.83M | 7.69M | 8.26M | n/a | 7.74M | n/a | n/a | n/a |
Other Working Capital | n/a | -54.5M | -1.17M | -12.34M | -3.09M | -1.64M | 35.23M | 17.06M | 7.35M | -6.21M | 18.68M | -5.84M | 3.98M | 30.83M | 45.02M | 79.98M | -112.95M | 709K | 7.25M | -3.58M | -31.76M | 3.86M |
Other Non-Cash Items | -127.81M | 83.36M | 35.6M | 112.12M | 14.93M | 21.75M | 43.63M | 21.18M | 80.49M | 26.99M | 112.56M | 27.2M | 15.73M | 29.78M | -10.61M | -89.32M | 27.66M | -29.97M | 9.02M | 28.86M | 41.49M | 30.83M |
Deferred Income Tax | n/a | n/a | n/a | -23.36M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | n/a | -190.08M | -12.29M | -50.74M | -35.11M | -106.38M | 21.86M | 42.77M | -116.57M | -11.97M | 53.7M | -34.74M | -120.43M | 54.28M | -79.34M | 114.18M | 18.94M | 50.66M | -10.63M | -2.45M | -164.44M | 55.04M |
Operating Cash Flow | n/a | -28.73M | 130.32M | 118.45M | 83.82M | 7.41M | 118.08M | 141.77M | 39.66M | -4.41M | 135.82M | 81.39M | -11.35M | 139.71M | -23.29M | 93.57M | -125.52M | 76.35M | 63.26M | 82.36M | -51.93M | 148.13M |
Capital Expenditures | n/a | -13.86M | -43.17M | -15.05M | -26.5M | -18.32M | -23.06M | -20.71M | -10.7M | -19.76M | -31.69M | -13.48M | -12.28M | -11.74M | -11.47M | -17.53M | -17.12M | -10.79M | -18.05M | -10.65M | -7.81M | -11.78M |
Cash Acquisitions | n/a | n/a | 715K | n/a | 855K | n/a | 7.01M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -84.71M | -72.72M | n/a | -73.83M | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | n/a | n/a | n/a | -7.41M | n/a | -4.64M | -600K | -3.6M | 4.24M | -9.7M | -19.9M | -1M | -1.15M | -338K | n/a | -31.8M | -9M | -1.89M | 3.8M | -988K | -750K | -917K |
Investing Cash Flow | n/a | -21.71M | -45.45M | -22.46M | -26.55M | -17.8M | -16.06M | -20.71M | -6.47M | -19.76M | -31.69M | -13.48M | -12.28M | -11.74M | -11.47M | -49.33M | -16.12M | -97.4M | -86.97M | -11.63M | -82.89M | -12.69M |
Debt Repayment | n/a | -6.17M | -6.12M | 67.21M | -17.29M | -17.53M | -55.54M | -87.21M | -27M | -15.38M | 64.16M | -53.94M | 5.09M | 7.34M | -17.65M | -42.61M | 31.79M | -9.8M | -9.85M | -34.36M | -12.25M | -22.72M |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -194K | -159K | n/a | n/a | n/a | n/a | n/a | -88K | -192K | n/a | n/a | -69K | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | n/a | -50.94M | -4.55M | -8.42M | -25.08M | -21.71M | -5.67M | -4.94M | -7.93M | -7.81M | -164.99M | -32.64M | -17.35M | -20.24M | -4.43M | -3.33M | -8.54M | -7.89M | -20.44M | -9.34M | -25.83M | -4.1M |
Financial Cash Flow | n/a | -57.07M | -10.12M | 59.44M | -41.69M | -39.17M | -61.2M | -92.35M | -35.09M | -23.16M | -100.83M | -86.59M | -12.26M | -12.9M | -22.17M | -46.13M | 23.25M | -17.57M | -30.35M | -43.56M | -38.07M | -26.15M |
Net Cash Flow | n/a | -109.04M | 74.9M | 154.79M | 15.42M | -50.03M | 40.08M | 28.72M | -2M | -47.49M | 3.5M | -18.98M | -36.49M | 115.84M | -60.66M | -2.29M | -118.36M | -40.19M | -53.88M | 27.47M | -172.66M | 108.69M |
Free Cash Flow | n/a | -42.59M | 87.15M | 103.4M | 57.32M | -10.91M | 95.01M | 121.06M | 28.95M | -24.17M | 104.13M | 67.91M | -23.63M | 127.98M | -34.76M | 76.04M | -142.64M | 65.55M | 45.21M | 71.72M | -59.74M | 136.35M |
Adj. Free Cash Flow | -10.39M | -42.59M | 78.94M | 95.18M | 49.04M | -18.17M | 87.8M | 113.95M | 22.23M | -30.89M | 98.16M | 61.22M | -30.19M | 120.38M | -42.59M | 68.35M | -150.9M | 65.55M | 37.47M | 71.72M | -59.74M | 136.35M |
Maintenance CapEx | n/a | n/a | -21.98M | n/a | -20.76M | -9.16M | n/a | n/a | n/a | n/a | -29.45M | n/a | n/a | n/a | n/a | -11.86M | -9M | -9.28M | -8.6M | -7.37M | n/a | -11.78M |
Growth CapEx | n/a | -13.86M | -21.18M | -15.05M | -5.75M | -9.16M | -23.06M | -20.71M | -10.7M | -19.76M | -2.24M | -13.48M | -12.28M | -11.74M | -11.47M | -5.67M | -8.12M | -1.51M | -9.45M | -3.27M | -7.81M | n/a |
Owner Earnings | n/a | -28.73M | 108.33M | 118.45M | 63.06M | -1.76M | 118.08M | 141.77M | 39.66M | -4.41M | 106.37M | 81.39M | -11.35M | 139.71M | -23.29M | 81.71M | -134.52M | 67.07M | 54.66M | 74.99M | -51.93M | 136.35M |
Add to Watchlist
Select watchlists to add or remove AMRX